Special Issue: Innovative Biomarker Discovery and Precision Medicine in Cancer Diagnostics

Open Medicine (Impact Factor: 1.6, JCR Q2)

Special Issue: Innovative Biomarker Discovery and Precision Medicine in Cancer Diagnostics

* All presenters of abstracts (either poster or oral) for CMID 2025 are eligible to submit a full paper to the special issue.

* All submissions will be subject to the journal’s standard peer review process, handled by the guest editors.

Topics of interest include, but are not limited to:

●New diagnostic biomarker for early detection of cancer 

●Proteomics and metabolomics in cancer diagnosis 

●Latest approaches to personalized cancer diagnosis and therapy 

●Clinical validation and translational challenges of new biomarkers 

●Application of liquid biopsy in minimally invasive cancer detection and real-time disease monitoring 

●Application of artificial intelligence in biomarker discovery and cancer imaging 

●Minimally invasive diagnostic technologies for cancer detection, monitoring and personalized treatment 

●Biomarker-driven targeted therapy and personalized treatment 

●Technological advances in innovative biomarker discovery and analysis 

●Ethical, legal, and social implications of biomarker use in cancer diagnosis

More details of the special issue, please find at: https://www.degruyter.com